• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌患者的一级亲属即使粪便免疫化学检测阴性,也可能存在进展期结直肠肿瘤。

First-degree relatives of colorectal cancer patients are likely to show advanced colorectal neoplasia despite a negative fecal immunochemical test.

机构信息

Department of Internal Medicine, Kyung Hee University Hospital at Gang Dong, Seoul, Republic of Korea.

出版信息

Digestion. 2012;86(4):283-7. doi: 10.1159/000341738. Epub 2012 Oct 9.

DOI:10.1159/000341738
PMID:23051697
Abstract

BACKGROUND/AIMS: Fecal immunochemical test (FIT) is an integral component of most colorectal cancer (CRC) screening programs. However, little is known about clinical risk factors associated with advanced colorectal neoplasia (CRN) despite negative FIT results. The aim of this study was to determine the clinical predictors of advanced CRN despite negative FIT results.

METHODS

We performed FITs for asymptomatic subjects ≥50 years from January 2009 to December 2010. Patients who underwent colonoscopy for a medical check-up, despite a negative FIT result, were included to evaluate the clinical predictors of advanced CRN based on colonoscopy.

RESULTS

During the study period, 373 subjects underwent screening colonoscopy despite their negative FIT results. Among those 373 subjects, 356 (95.4%) did not show any advanced CRNs; however, 17 (4.6%) subjects showed advanced CRNs on their colonoscopies despite negative FIT results. Being a first-degree relative of a CRC patient was significantly associated with advanced CRNs in univariate analysis (p = 0.031). According to multivariate logistic regression analysis, being a first-degree relative of a CRC patient was a significant predictor of advanced CRNs despite negative FIT results (OR 7.33; 95% CI, 0.53-35.08; p = 0.013).

CONCLUSION

First-degree relatives of CRC patients are likely to show advanced CRNs despite a negative FIT.

摘要

背景/目的:粪便免疫化学检测(FIT)是大多数结直肠癌(CRC)筛查计划的重要组成部分。然而,尽管 FIT 结果为阴性,与进展期结直肠肿瘤(CRN)相关的临床危险因素却知之甚少。本研究旨在确定尽管 FIT 结果为阴性,但仍存在进展期 CRN 的临床预测因素。

方法

我们对 2009 年 1 月至 2010 年 12 月期间≥50 岁的无症状患者进行了 FIT 检测。对于因 FIT 检测结果为阴性而进行结肠镜检查的患者,我们纳入了此项研究,以评估基于结肠镜检查的进展期 CRN 的临床预测因素。

结果

在研究期间,有 373 名患者因 FIT 检测结果为阴性而接受了筛查性结肠镜检查。在这 373 名患者中,有 356 名(95.4%)未出现任何进展期 CRN;然而,有 17 名(4.6%)患者尽管 FIT 检测结果为阴性,但在结肠镜检查中出现了进展期 CRN。在单因素分析中,CRC 患者的一级亲属与进展期 CRN 显著相关(p=0.031)。根据多因素逻辑回归分析,CRC 患者的一级亲属是尽管 FIT 检测结果为阴性但仍存在进展期 CRN 的显著预测因素(OR 7.33;95% CI,0.53-35.08;p=0.013)。

结论

CRC 患者的一级亲属尽管 FIT 检测结果为阴性,但仍可能出现进展期 CRN。

相似文献

1
First-degree relatives of colorectal cancer patients are likely to show advanced colorectal neoplasia despite a negative fecal immunochemical test.结直肠癌患者的一级亲属即使粪便免疫化学检测阴性,也可能存在进展期结直肠肿瘤。
Digestion. 2012;86(4):283-7. doi: 10.1159/000341738. Epub 2012 Oct 9.
2
Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.粪便免疫化学检测与结肠镜检查在家族性结直肠癌筛查中的等效性。
Gastroenterology. 2014 Nov;147(5):1021-30.e1; quiz e16-7. doi: 10.1053/j.gastro.2014.08.004. Epub 2014 Aug 13.
3
Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.粪便检测阴性的结直肠癌患者发生高级别腺瘤风险较低。
Gastroenterology. 2012 Mar;142(3):497-504. doi: 10.1053/j.gastro.2011.11.024. Epub 2011 Nov 19.
4
Effectiveness of a colonoscopic screening programme in first-degree relatives of patients with colorectal cancer.结直肠癌患者一级亲属结肠镜筛查计划的效果。
Colorectal Dis. 2011 Jun;13(6):e145-53. doi: 10.1111/j.1463-1318.2011.02577.x.
5
One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.采用粪便潜血联合检测及远端结肠检查进行一次性结直肠癌筛查。
N Engl J Med. 2001 Aug 23;345(8):555-60. doi: 10.1056/NEJMoa010328.
6
Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia.免疫化学粪便潜血试验对近端和远端进展期肿瘤同样敏感。
Am J Gastroenterol. 2012 Oct;107(10):1570-8. doi: 10.1038/ajg.2012.249. Epub 2012 Jul 31.
7
Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study.采用高敏免疫化学粪便隐血试验筛查家族性结直肠癌:一项初步研究。
Eur J Gastroenterol Hepatol. 2009 Sep;21(9):1062-7. doi: 10.1097/MEG.0b013e3283293797.
8
A combination of clinical risk stratification and fecal immunochemical test results to prioritize colonoscopy screening in asymptomatic participants.将临床风险分层与粪便免疫化学检测结果相结合,以优先对无症状参与者进行结肠镜筛查。
Gastrointest Endosc. 2015 Mar;81(3):719-27. doi: 10.1016/j.gie.2014.11.035.
9
An analysis of the duplicate testing strategy of an Irish immunochemical faecal occult blood test colorectal cancer screening programme.爱尔兰免疫化学粪便潜血试验结直肠癌筛查项目重复检测策略分析。
Colorectal Dis. 2013 Sep;15(9):e512-21. doi: 10.1111/codi.12310.
10
Role of preoperative colonoscopy in patients with gastric cancer: a case control study of the prevalence of coexisting colorectal neoplasms.术前结肠镜检查在胃癌患者中的作用:一种同时存在结直肠肿瘤患病率的病例对照研究。
Ann Surg Oncol. 2013 May;20(5):1614-22. doi: 10.1245/s10434-012-2737-0. Epub 2013 Jan 30.

引用本文的文献

1
Liquid Biopsy as a Source of Nucleic Acid Biomarkers in the Diagnosis and Management of Lynch Syndrome.液体活检作为林奇综合征诊断和管理中核酸生物标志物的来源。
Int J Mol Sci. 2022 Apr 13;23(8):4284. doi: 10.3390/ijms23084284.
2
Participant-Related Risk Factors for False-Positive and False-Negative Fecal Immunochemical Tests in Colorectal Cancer Screening: Systematic Review and Meta-Analysis.参与者相关的粪便免疫化学检测在结直肠癌筛查中的假阳性和假阴性的危险因素:系统评价和荟萃分析。
Am J Gastroenterol. 2018 Dec;113(12):1778-1787. doi: 10.1038/s41395-018-0212-7. Epub 2018 Aug 29.
3
Uncovering the barriers to undergoing screening among first degree relatives of colorectal cancer patients: a review of qualitative literature.
揭示结直肠癌患者一级亲属接受筛查的障碍:定性文献综述
J Gastrointest Oncol. 2018 Jun;9(3):579-588. doi: 10.21037/jgo.2018.03.02.